lobbying_activities: 1844236

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1844236	00e57268-6b44-4bd9-bc0f-980fbf9fa4c3	Q2	HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC	17966	EMERGENT BIOSOLUTIONS	2016	second_quarter	MED	H.R. 4400 and S. 2512 (P.L. 114 - 146) - Adding Zika Virus to the FDA Priority Review Program Act - entire bill.	HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2016-07-15T15:48:08.300000-04:00